New York, NY — April 11, 2023 — Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that it has raised $30 million in Series B funding led by Koch Disruptive Technologies (KDT) and joined by existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. This funding will bolster the company’s market leadership and momentum, as its recent clinical study results are driving accelerated contracting with payers and employers to reimburse access to Oshi Health as a covered benefit. The rigorous clinical trial of Oshi Health’s differentiated clinical model, conducted by a national health plan in a large commercially insured population, showed 92% of patients report symptom improvement with 98% patient satisfaction. These outcomes are even more significant in conjunction with driving all-cause medical cost savings of $10,292 per patient in just six months.
Add A Comment